Vega raises $120M Series B to rethink how enterprises detect cyber threats

Vega Security raised $120 million Series B, bringing its valuation to $700 million, in a round led by Accel. The company aims to rethink how enterprises detect cybersecurity threats.

Hauler Hero collects $16M for its AI waste management software

Hauler Hero has seen its customer base, revenue, and head count double since the company raised its seed round in 2024.

India orders social media platforms to take down deepfakes faster

India’s new rules take effect February 20, tightening deepfake oversight and shrinking takedown windows to as little as two hours.

AI video startup Runway raises $315M at $5.3B valuation, eyes more capable world models

Startup Runway has raised a $315 million round at a $5.3 billion valuation, funds it will use to expand beyond AI video generation and into world models.

Tem raises $75M to remake electricity markets using AI

Tem has built a transaction engine that relies on AI to cut costs. Lightspeed led the round to help the startup expand to the U.S. and Australia.

Anthropic’s India expansion collides with a local company that already had the name

India’s Anthropic Software has taken the U.S. AI giant to court over a name dispute.

Hacktivist scrapes over 500,000 stalkerware customers’ payment records

More than half-a-million people who bought access to phone surveillance and social media snooping apps had their email address and partial payment card numbers published online.

Prince Andrew advisor pitched Jeffrey Epstein on investing in EV startups like Lucid Motors

The mysterious businessman pitched Jeffrey Epstein on numerous mobility startups in an era when the sector was white hot, according to TechCrunch’s review of hundreds of documents released by the Department of Justice.

Maybe AI agents can be lawyers after all

This week’s release of Opus 4.6 shook up the agentic AI leaderboards.

How AI is helping solve the labor issue in treating rare diseases

At Web Summit Qatar, AI-powered biotech startups describe how automation, data, and gene editing are filling labor gaps in drug discovery and rare disease treatment.